ClinVar Miner

Submissions for variant NM_000277.3(PAH):c.241A>C (p.Thr81Pro)

gnomAD frequency: 0.00001  dbSNP: rs62509017
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen PAH Variant Curation Expert Panel RCV001192889 SCV005442782 likely pathogenic Phenylketonuria 2024-11-17 reviewed by expert panel curation The c.241A>C (p.Thr81Pro) variant in PAH has been reported in at least two individuals with classic PKU, where it was observed without confirmed phase with c.117C>G (p.Phe39Leu) (classified as pathogenic by PAH VCEP Variation ID 605) and c.842+1G>A (classified as pathogenic by PAH VCEP Variation ID 599) (PMID: 8659548, PMID: 9169088, PMID: 11328945). It has also been described without a specified subtype or phase with two additional pathogenic variants: p.R408W (Variation ID: 577, PMID: 23430918); c.822_832del (p.Lys274fs) (Variation ID: 102852, PMID: 23430918). Exclusion of BH4 deficiency was not specified. In-vitro functional studies are unavailable. This variant has extremely low frequency in gnomAD v4.1.0 (MAF=0.000007629). In-silico predictions support pathogenicity of this variant (REVEL=0.74). Another missense variant [c.242C>A (p.Thr81Asn)] in the same codon has been classified as likely pathogenic by the ClinGen Phenylketonuria Variant Curation Expert Panel. In summary, this variant is likely pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PM3_strong, PP4, PM2_supporting, PM5_supporting, PP3.
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000088881 SCV001134523 pathogenic not provided 2023-11-17 criteria provided, single submitter clinical testing The PAH c.241A>C (p.Thr81Pro) variant has been reported in the published literature in individuals with Phenylketonuria (PKU), including classical PKU cases and maternal PKU cases (PMIDs: 32668217 (2020), 23430918 (2012), 11328945 (2001), 10541324 (1999), 10429004 (1999), 9169088 (1997), 8659548 (1996)). Additionally, this variant has been associated with BH4 unresponsiveness (PMID: 23430918 (2012)). The frequency of this variant in the general population, 0.000015 (1/68014 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is consistent with pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is damaging. Based on the available information, this variant is classified as pathogenic.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV001192889 SCV001361329 likely pathogenic Phenylketonuria 2019-10-31 criteria provided, single submitter clinical testing Variant summary: PAH c.241A>C (p.Thr81Pro) results in a non-conservative amino acid change located in the ACT domain (IPR002912) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251436 control chromosomes (gnomAD). c.241A>C has been reported in the literature in individuals affected with Phenylalanine Hydroxylase Deficiency (Phenylketonuria) (Guldberg_1996, Sarkissian_2012, Enns_1999). These data indicate that the variant is likely to be associated with disease. Another variant affecting the same codon (c.242C>A, p.T81N) has been classified as likely pathogenic in ClinVar by the ClinGen PAH Variant Curation Expert Panel (Variation ID: 208180). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.
Labcorp Genetics (formerly Invitae), Labcorp RCV001192889 SCV001414753 pathogenic Phenylketonuria 2023-11-04 criteria provided, single submitter clinical testing This sequence change replaces threonine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 81 of the PAH protein (p.Thr81Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with phenylketonuria (PMID: 8659548, 23430918). ClinVar contains an entry for this variant (Variation ID: 102637). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PAH protein function with a negative predictive value of 80%. For these reasons, this variant has been classified as Pathogenic.
Baylor Genetics RCV001192889 SCV004209676 pathogenic Phenylketonuria 2023-04-25 criteria provided, single submitter clinical testing
DeBelle Laboratory for Biochemical Genetics, MUHC/MCH RESEARCH INSTITUTE RCV000088881 SCV000119478 not provided not provided no assertion provided not provided

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.